Chicago had been on a steady climb of dose administration until this week. The city saw its federal vaccine supply drop by 35,000 from the week of April 5 to the week of April 12. Those doses were all Johnson & Johnson, a likely result of the manufacturing mixup announced at the end of March. Now with J&J use on indefinite pause, the city must rely on its supply of Moderna and Pfizer for its vaccination campaign.